• LAST PRICE
    3.4300
  • TODAY'S CHANGE (%)
    Trending Down-0.0600 (-1.7192%)
  • Bid / Lots
    3.4300/ 7
  • Ask / Lots
    3.4400/ 29
  • Open / Previous Close
    3.5400 / 3.4900
  • Day Range
    Low 3.4250
    High 3.6300
  • 52 Week Range
    Low 3.3700
    High 11.6900
  • Volume
    1,216,511
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 3.49
TimeVolumeEDIT
09:32 ET182273.525
09:34 ET108573.5203
09:36 ET35953.525
09:38 ET79623.564
09:39 ET192793.58
09:41 ET292583.58
09:43 ET427993.585
09:45 ET181283.585
09:48 ET170183.6
09:50 ET291193.615
09:52 ET207753.59
09:54 ET189973.5826
09:56 ET191093.594
09:57 ET915123.54
09:59 ET31913.54
10:01 ET76843.54
10:03 ET13003.55
10:06 ET121283.545
10:08 ET37083.54
10:10 ET14483.5401
10:12 ET5793.545
10:14 ET24803.54
10:15 ET23523.535
10:17 ET22923.525
10:19 ET188643.515
10:21 ET26803.52
10:24 ET5003.5262
10:26 ET49043.54
10:28 ET33973.535
10:30 ET45963.525
10:32 ET18063.515
10:33 ET37963.505
10:35 ET117803.5
10:37 ET129333.506
10:39 ET371313.515
10:42 ET45233.52
10:44 ET18093.53
10:46 ET572673.535
10:48 ET65313.525
10:50 ET55963.535
10:51 ET45763.53
10:53 ET54873.53
10:55 ET61473.52
10:57 ET31613.495
11:00 ET30043.51
11:02 ET50263.505
11:04 ET13003.505
11:06 ET44503.5
11:08 ET28003.49
11:09 ET80163.5
11:11 ET72903.5
11:13 ET17503.495
11:15 ET34393.505
11:18 ET164503.505
11:20 ET23093.509
11:22 ET49623.495
11:24 ET20323.49
11:26 ET71663.48
11:27 ET16003.48
11:29 ET3503.48
11:31 ET6113.49
11:33 ET38633.4998
11:36 ET9853.495
11:38 ET27603.499
11:40 ET49703.485
11:42 ET17853.485
11:44 ET39063.49
11:45 ET117593.4988
11:47 ET7003.495
11:49 ET53403.51
11:51 ET66733.5001
11:54 ET34333.495
11:56 ET3003.495
11:58 ET26783.5011
12:00 ET194453.5
12:02 ET332993.475
12:03 ET67123.5
12:05 ET86673.505
12:07 ET12513.5
12:09 ET50123.495
12:12 ET50743.49
12:14 ET7443.495
12:16 ET115793.475
12:18 ET22543.475
12:20 ET156013.47
12:21 ET66143.4635
12:23 ET29953.46
12:25 ET42363.465
12:27 ET32233.465
12:30 ET8003.465
12:32 ET92073.465
12:34 ET33103.47
12:36 ET15053.465
12:39 ET26373.475
12:41 ET13863.475
12:43 ET37893.465
12:45 ET3003.465
12:48 ET8003.465
12:50 ET7003.46
12:52 ET216723.46
12:54 ET7003.47
12:56 ET19413.46
12:57 ET15223.46
12:59 ET21503.45
01:01 ET23103.455
01:03 ET21413.465
01:06 ET1003.465
01:08 ET27323.46
01:10 ET60363.4598
01:12 ET30243.45
01:14 ET3503.45
01:15 ET17113.4589
01:17 ET18333.45
01:19 ET81953.465
01:21 ET13003.47
01:24 ET7203.4799
01:26 ET15703.4829
01:28 ET15603.4809
01:30 ET215213.49
01:32 ET7003.5
01:33 ET45803.495
01:35 ET11003.495
01:37 ET4223.495
01:39 ET157093.4807
01:42 ET93893.4834
01:44 ET67333.465
01:46 ET80883.4609
01:48 ET20343.475
01:50 ET2223.475
01:51 ET5503.475
01:53 ET30503.475
01:55 ET4113.475
01:57 ET6893.475
02:00 ET12613.4735
02:02 ET5813.475
02:04 ET50253.47
02:06 ET14003.47
02:08 ET145083.465
02:09 ET17253.45
02:11 ET55603.4635
02:13 ET5003.4667
02:15 ET25923.479
02:18 ET15173.475
02:20 ET51173.47
02:22 ET29643.455
02:24 ET24283.46
02:26 ET14773.4546
02:27 ET143403.445
02:29 ET6203.45
02:31 ET27013.445
02:33 ET78473.445
02:36 ET90033.43
02:38 ET13543.43
02:40 ET64603.435
02:42 ET8043.4398
02:44 ET64543.436
02:45 ET49203.435
02:47 ET22073.445
02:49 ET4373.445
02:51 ET51953.45
02:54 ET6893.44
02:56 ET65013.43
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesEDIT
Editas Medicine Inc
287.8M
-1.5x
---
United StatesPSNL
Personalis Inc
292.6M
-3.2x
---
United StatesCDXC
Chromadex Corp
287.0M
-210.6x
---
United StatesADCT
ADC Therapeutics SA
290.1M
-1.2x
---
United StatesENTA
Enanta Pharmaceuticals Inc
221.8M
-1.9x
---
United StatesPSTX
Poseida Therapeutics Inc
288.4M
-2.4x
---
As of 2024-09-27

Company Information

Editas Medicine, Inc. is a clinical-stage genome editing company. The Company is focused on developing potentially transformative genomic medicines to treat a broad range of serious diseases. It has developed a proprietary gene editing platform based on CRISPR technology. CRISPR uses a protein- ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1), bound to a guide ribonucleic acid (RNA) molecule designed to recognize a particular deoxyribonucleic acid (DNA) sequence. It is engaged in the development of vivo administered gene editing medicines, in which the medicine is injected or infused into the patient to edit the cells inside their body. Its lead program, reni-cel, is an experimental ex vivo gene-edited medicine to treat sickle cell disease (SCD), a severe inherited blood disease that causes premature death, and transfusion-dependent beta thalassemia (TDT).

Contact Information

Headquarters
11 Hurley StCAMBRIDGE, MA, United States 02141-2110
Phone
617-401-9000
Fax
302-655-5049

Executives

Independent Chairman of the Board
Emma Reeve
President, Chief Executive Officer, Director
Gilmore O'Neill
Chief Financial Officer, Executive Vice President
Erick Lucera
Executive Vice President, Chief Scientific Officer
Linda Burkly
Senior Vice President, Chief Medical Officer
Baisong Mei

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$287.8M
Revenue (TTM)
$67.0M
Shares Outstanding
82.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.99
EPS
$-2.36
Book Value
$4.27
P/E Ratio
-1.5x
Price/Sales (TTM)
4.3
Price/Cash Flow (TTM)
---
Operating Margin
-317.78%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.